In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...
As the world observes HIV/AIDS Awareness Month, attention turns to education, stigma reduction, and empowering communities to confront the epidemic. Recognized each December in the United States, this ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...
Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The ...
HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life expectancy for people living with HIV. Nearly 41 million people were ...
With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...
The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...
When you’re living with HIV, there are a few health markers that your doctor will use to keep track of your care. One of them ...
HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...
The tools to stop the spread of HIV are readily available, but experts said they're not getting to the right people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback